DiamiR Announces SBIR Phase I Award for Aging Program
07 juin 2016 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - June 07, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests, announced today that the National Institute on Aging (NIA) of the...
Cantabio Pharmaceuticals Announces the Development of Small Molecule Chaperones of the Abeta Peptide for the Treatment of Alzheimer's Disease in Collaboration with NovAliX
12 avr. 2016 12h00 HE
|
Cantabio Pharmaceuticals Inc.
PALO ALTO, Calif., April 12, 2016 (GLOBE NEWSWIRE) -- Cantabio Pharmaceuticals Inc. (OTCQB:CTBO) announced today a new preclinical therapeutic program for Alzheimer’s Disease which it is...
CANTABio and Gardedam Therapeutics complete Merger to Tackle Development of Novel Therapeutics for Alzheimer's and Parkinson's Disease
21 déc. 2015 13h00 HE
|
Cantabio Pharmaceuticals Inc.
PALO ALTO, Calif., Dec. 21, 2015 (GLOBE NEWSWIRE) -- Cantabio Pharmaceuticals, Inc. ("Cantabio") (OTCQB:CTBO) is pleased to announce the completion of its reverse merger (the "Merger") with...
DiamiR Announces $1.5M SBIR Phase II Funding for Further Evaluation of the microRNA Biomarkers for Early Detection of Alzheimer's Disease
16 mars 2015 08h02 HE
|
DiamiR
MONMOUTH JUNCTION, NJ--(Marketwired - March 16, 2015) - DiamiR, LLC, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the National Institute...
DiamiR Announces Oral Presentation at the 2014 Alzheimer's Association International Conference
10 juil. 2014 08h02 HE
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - July 10, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative tests for detection and monitoring...
DiamiR Announces Presentation at the 2014 BIO International Convention
18 juin 2014 08h00 HE
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - June 18, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative tests for detection and monitoring...
DiamiR Announces Poster Presentation on Detection and Differentiation of Neurodegenerative Diseases at the Biomarkers & Diagnostics World Congress 2014
28 avr. 2014 08h00 HE
|
DiamiR LLC
MONMOUTH JUNCTION, NJ--(Marketwired - April 28, 2014) - DiamiR, LLC, a molecular diagnostics company focused on the development and commercialization of innovative blood-based...